Digestive System TRIZ Cases

Adding solid carriers like sugars to liquid Pelargonium extracts reduces solvent content and improves solubility for pharmaceutical processing.

Dihydro-lipoic acid neutralizes hydrogen peroxide to reverse mitochondrial DNA oxidative damage, avoiding immunosuppressive side effects.

A thiazolidinedione derivative compound treats fatty liver disease by modulating lipid metabolism and reducing liver damage indicators.

Anti-HLA-DQ2.5/8 antibodies bind to specific molecules and block interaction with T cells despite unintentional gluten contamination.

Aprotic solvent modulates polyorthoester release kinetics, tailoring drug delivery profiles from rapid onset to sustained action over weeks.

Fully human antibodies bind CD147 epitopes with high affinity using optimized variable region sequences to treat CD147-expressing tumors.

Tri-substituted starch esters incorporate acetate, propionate, and butyrate linkages to enhance microbial SCFA production without DMSO solvents.

NP137 neutralizes netrin-1 to reduce hepatic inflammation and fibrogenesis while preserving hepatocyte survival.

Clostridiales probiotics restore gut flora balance, reducing bloating and cramping from cruciferous vegetables.

Monofunctional aldehydes form separable aldehyde-bisulfite complexes, removing bisulfite while preserving catalytic activity under neutral conditions.

Osmotic stress and flow shear remove cells while preserving extracellular matrix integrity for disease modeling.

IL22RA2 gene locus replaces invasive liver biopsy with genetic testing to predict fibrosis progression and optimize antiviral treatment selection.

Cyclic peptides activate the Guanylate Cyclase C receptor to enhance fluid secretion, resolving patient intolerance issues in colon preparation.

Sangivamycin analogs bind Ebola VP40 proteins to block viral particle assembly, preventing infectious virion formation.

An intermittent flow extrusion process creates composite pet treats with a bone-like inner core and meaty outer shell.

DPP-4 inhibitors treat non-alcoholic fatty liver disease by modulating endogenous GLP-1 levels to enhance insulin secretion.

A Pediococcus-based probiotic composition restores gut microbiota balance and enhances immune response in mammals.

A macroporous biomaterial scaffold supports tissue regeneration through physical crosslinking and lyophilization.

Optimized fully human anti-CD137 antibodies resolve specificity and affinity trade-offs to enhance T cell activation.

TNP purine inhibits JNK phosphorylation to prevent acetaminophen-induced liver toxicity.

Tangential flow filtration isolates active fractions from Graptopetalum paraguayense extracts using ultrafiltration membranes.

A bispecific antibody links FolR1-expressing tumor cells to CD3 on T cells to drive localized immune activation.

Recombinant albumin conjugates bind specifically to Cysteine 34 via cleavable linkers for targeted delivery.

An inverted heat exchanger arrangement eliminates separator units to reduce pressure loss and protect equipment from contamination.